News 9 Oct 2026 DNDi 2026 Projects of the Year recognize teams and partners for their work to advance an open-science antiviral for future coronavirus pandemics and a single-dose treatment for sleeping sickness
Press releases 6 Oct 2026 Ghana’s KNUST and DNDi partner to accelerate drug discovery for neglected diseases in Africa
Scientific articles 5 Oct 2026 Winning the endgame against sleeping sickness: Efficacy profiling of acoziborole against African trypanosomes with the focus on Trypanosoma brucei rhodesiense PLoS Neglected Tropical Diseases
Statements 25 Sep 2026 DNDi intervention at the UN High-Level Meeting on Pandemic Prevention, Preparedness, and Response at the 81st UN General Assembly
In the media 24 Sep 2026 De Etiopía a Lleida: la desigualdad mata tanto como los virus durante una pandemia El País
Scientific articles 19 Sep 2026 Thermotherapy compared with intralesional sodium stibogluconate for Leishmania aethiopica cutaneous Leishmaniasis in Ethiopia: A phase II randomized controlled trial BMC Medicine
News 15 Sep 2026 New DNDi report: Implementing Article 9.5 of the WHO Pandemic Agreement – building on current policy and practice for publicly funded R&D
In the media 9 Sep 2026 Des acteurs pharmaceutiques à but non lucratif s’allient pour faire face à la baisse des financements Swissinfo
Press releases 15 Sep 2019 La cuvée 2018 de la ‘Vigne des Nations’ de la République et canton de Genève dédiée à DNDi en reconnaissance de son travail auprès des patients les plus négligés
Press releases 22 Jul 2019 Patients treated for visceral leishmaniasis can still transmit the disease even after completing treatment, study shows
Press releases 17 Jul 2019 Nationwide hepatitis C screening campaign initiated by the Malaysian Ministry of Health
Press releases 20 Jun 2019 Chagas Access Programme achieves an increase of 1300% in the number of people screened
Press releases 24 May 2019 Following 110 years of neglect, an official day for Chagas disease is declared
Press releases 16 Apr 2019 DNDi and Atomwise collaborate to advance drug development using AI for neglected diseases
Press releases 14 Mar 2019 Study shows dramatically shorter treatment for Chagas disease could be just as effective, and significantly safer
Press releases 5 Feb 2019 Wellcome commits £10 million to DNDi to develop new generation of oral drugs to treat leishmaniasis
Press releases 30 Jan 2019 Fexinidazole, the first all-oral treatment for sleeping sickness, approved in Democratic Republic of Congo
Press releases 29 Jan 2019 MMV and DNDi make 400 compounds available to stimulate research into new drugs for pandemic diseases
Press releases 23 Jan 2019 Drugs for Neglected Diseases initiative and The BMJ launch a special collection on neglected diseases and innovation in South Asia
Press releases 17 Jan 2019 Combination therapy found to be more effective in treating patients with leishmaniasis and HIV
Press releases 16 Nov 2018 European Medicines Agency recommends fexinidazole, the first all-oral treatment for sleeping sickness
Press releases 12 Sep 2018 New hope for PKDL patients in Africa as clinical trial aims to make treatment safer and easier
